Rezaee, Mehdi; Keshavarz, Khosro; Izadi, Sadegh; … - In: Health Economics Review 12 (2022) 1, pp. 1-10
Background: Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a heavy socioeconomic burden on societies. This study aimed to determine the economic burden of MS on patients using the first (CinnoVex and ReciGen) and second (Fingolimod and Natalizumab) drug therapy lines....